HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer
Titel:
HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer
Auteur:
Bergamino, Milana A. López-Knowles, Elena Morani, Gabriele Tovey, Holly Kilburn, Lucy Schuster, Eugene F. Alataki, Anastasia Hills, Margaret Xiao, Hui Holcombe, Chris Skene, Anthony Robertson, John F. Smith, Ian E. Bliss, Judith M. Dowsett, Mitch Cheang, Maggie C.U.